HomeAbout SNHPAMembership InformationCorporate PartnersMembers OnlyEvents340B ResourcesAdvocacyCareers/Rx Job SolutionsLinksNews
Welcome, Guest!
Member
Login:
Forgot your
password?
Home
About SNHPA
 
Contact Us
Staff and Counsel
Board of Directors
Careers
Membership Information
Corporate Partners
Members Only
Events
340B Resources
Advocacy
Rx Job Solutions
Links
News
Search SNHPA

 Home > About SNHPA > SNHPA Staff and Counsel > Miriam Lasar
Miriam Lasar
Director of Finance and Administration

Phone: 202-552-5858
Fax: 202-552-5868
E-Mail: miriam.lasar@safetynetrx.org

Miriam Lasar is the Director of Finance and Administration for Safety Net Hospitals for Pharmaceutical Access (SNHPA), an organization of more than 400 hospitals participating in the 340B drug discount program.  Ms. Lasar provides financial analysis and support in addition to overseeing office administration.  Before joining SNHPA, Ms. Lasar worked at an enterprise software company as their controller and in investment banking performing equity analysis and research.

She graduated cum laude with a B.A. in Economics from Brandeis University in 1999, where she was a Brandeis Presidential Scholar.  Ms. Lasar received her M.B.A. from the Robert H. Smith School of Business at the University of Maryland at College Park in 2006.
 
Federal Drug Discount and Compliance Monitor Learn more about The Monitor, a monthly publication covering the latest news in the 340B program and other federal drug discount programs.
Untitled Document

PLATINUM CORPORATE PARTNERS
AmerisourceBergen Drug Company

AmerisourceBergen Solutions Group
McKesson

NEChealth Network
Pharmacy Healthcare Solutions

Sentry Data Systems
Talyst

Wellpartner, Inc.

GOLD CORPORATE PARTNERS

American Health Care Cardinal Health Comprehensive Pharmacy Services Ernst & Young Global Pharmaceutical Solutions PDX-Rx.com

SILVER CORPORATE PARTNERS


NON-PROFIT AFFILIATES




1501 M Street NW 7th Floor Washington, DC 20005 Phone: 202-552-5850 Fax: 202-552-5868

© Copyright 2009 Safety Net Hospitals for Pharmaceutical Access